IRIS PubliCatt

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 149
Data di pubblicazione Titolo Autore(i) File
1-gen-2020 Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages Lisi, Lucia; Ciotti, G. M. P.; Chiavari, Marta; Ruffini, F.; Lacal, P. M.; Graziani, G.; Navarra, Pierluigi
1-gen-2020 Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation Chiavari, Marta; Ciotti, G. M. P.; Canonico, Francesco; Altieri, F.; Lacal, P. M.; Graziani, G.; Navarra, Pierluigi; Lisi, Lucia
1-gen-2020 A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials Dello Russo, Cinzia; Cappoli, Natalia; Navarra, Pierluigi
1-gen-2020 A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB Tringali, Giuseppe; Vollono, Catello; Calabresi, Paolo; Navarra, Pierluigi
1-gen-2020 Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections De Pascale, Gennaro; Lisi, Lucia; Ciotti, G. M. P.; Vallecoccia, M. S.; Cutuli, S. L.; Cascarano, Laura; Gelormini, C.; Bello, Giuseppe; Montini, Luca; Carelli, Simone; Di Gravio, V.; Tumbarello, Mario; Sanguinetti, Maurizio; Navarra, Pierluigi; Antonelli, Massimo
1-gen-2020 DNA inhibitors for the treatment of brain tumors Lisi, Lucia; Chiavari, Marta; Ciotti, Gabriella Maria Pia; Lacal, Pedro M; Navarra, Pierluigi; Graziani, Grazia
1-gen-2020 Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches Ricci, F.; Bandello, F.; Navarra, Pierluigi; Staurenghi, G.; Stumpp, M.; Zarbin, M.
1-gen-2020 Beyond antibodies: ankyrins and DARPins. From basic research to drug approval Caputi, A. P.; Navarra, Pierluigi
1-gen-2020 P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals Curro', D.; Navarra, P.; Samengo, I.; Martire, M.
1-gen-2020 Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples Lisi, Lucia; Ciotti, G. M. P.; Navarra, Pierluigi
1-gen-2020 The safety profile of probiotic VSL#3®. A meta-analysis of safety data from double-blind, randomized, placebo-controlled clinical trials Panetta, V.; Bacchieri, A.; Papetti, S.; Stefani, E. D. E.; Navarra, Pierluigi
1-gen-2019 Full HTA di Emicizumab Cicchetti, Americo; Berrino, A; Castaman, G; Rumi, F; Cortesi, P; Mantovani, L; Urbina, I; Midolo, Emanuela; Navarra, Pierluigi; Refolo, Pietro; Sacchini, Dario; Spagnolo, Antonio Gioacchino
1-gen-2019 Pro-inflammatory activation of a new immortalized human microglia cell line Chiavari, Marta; Ciotti, G. M. P.; Navarra, Pierluigi; Lisi, Lucia
1-gen-2019 Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation Pozzoli, Giacomo; Marei, Hany E.; Althani, Asma; Boninsegna Lucarelli, Alma; Casalbore, Patrizia; Marlier, Lionel N. J. L.; Lanzilli, Giulia; Zonfrillo, Manuela; Petrucci, Giovanna; Rocca, Bianca; Navarra, Pierluigi; Sgambato, Alessandro; Cenciarelli, Carlo
1-gen-2019 Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation. Pozzoli, Giacomo; Petrucci, Giovanna; Navarra, Pierluigi; Marei, He; Cenciarelli, C.
1-gen-2019 Phospho-mTOR expression in human glioblastoma microglia-macrophage cells Lisi, Lucia; Ciotti, G. M. P.; Chiavari, Marta; Pizzoferrato, Marco; Mangiola, A.; Kalinin, S.; Feinstein, D. L.; Navarra, Pierluigi
1-gen-2019 The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells Cappoli, Natalia; Mezzogori, D; Tabolacci, Elisabetta; Coletta, I; Navarra, Pierluigi; Pani, Giovambattista; Dello Russo, Cinzia
1-gen-2019 When innovation goes fast. The case of hemophilia Pilunni, D.; Montrasio, L.; Navarra, Pierluigi
1-gen-2019 Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis Tringali, Giuseppe; Navarra, Pierluigi
1-gen-2019 Optimizing Patient Selection to Maximize Drug Efficacy: the Expanding Role of Pharmacogenomics in the Clinical Development of Pembrolizumab for the Treatment of Non-small Cell Lung Cancer Dello Russo, Cinzia; Gagliardi, D.; Ramlogan, R.; Navarra, Pierluigi
Mostrati risultati da 21 a 40 di 149
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile